Ocean Biomedical, Inc. (OCEA)

Accolade Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	-	-	0	0.03	0.06	-
Cash & Short-Term Investments	-	-	0	0.03	0.06	-
Cash Growth	-	-	-88.23%	-43.33%	-	-
Prepaid Expenses	0.72	0.59	1.11	-	-	-
Restricted Cash	0.78	0.22	1	-	-	-
Other Current Assets	-	-	-	1.81	0.02	0.39
Total Current Assets	1.49	0.81	2.11	1.84	0.08	0.39
Long-Term Investments	0.09	0.09	3.39	-	-	-
Total Assets	1.58	0.9	5.5	1.84	0.08	0.39
Accounts Payable	0.96	0.8	0.93	-	0.24	0.05
Accrued Expenses	16.06	15.7	16.2	11.44	6.33	2.14
Short-Term Debt	9.35	16.3	12.12	1.22	0.18	0.08
Other Current Liabilities	0.2	1.09	0.76	-	-	-
Total Current Liabilities	26.57	33.89	30.01	12.66	6.74	2.27
Long-Term Debt	6	5.57	4.12	-	-	-
Other Long-Term Liabilities	61.41	59.06	62.13	-	-	-
Total Liabilities	93.98	98.52	96.26	12.66	6.74	2.27
Additional Paid-In Capital	121.38	107.92	105.29	70.77	57.57	-
Retained Earnings	-213.78	-205.54	-196.06	-81.59	-64.23	-1.89
Shareholders' Equity	-92.4	-97.62	-90.76	-10.82	-6.66	-1.89
Total Liabilities & Equity	1.58	0.9	5.5	1.84	0.08	0.39
Total Debt	15.35	21.87	16.24	1.22	0.18	0.08
Net Cash (Debt)	-15.35	-21.87	-16.24	-1.19	-0.12	-0.08
Net Cash Per Share	-0.35	-0.80	-0.62	-0.05	-0.01	-0.00
Filing Date Shares Outstanding	232.37	166.01	34.82	23.36	17.5	17.45
Total Common Shares Outstanding	166.01	34.87	34.65	23.36	17.5	17.45
Working Capital	-25.08	-33.08	-27.9	-10.82	-6.66	-1.89
Book Value Per Share	-0.56	-2.80	-2.62	-0.46	-0.38	-0.11
Tangible Book Value	-92.4	-97.62	-90.76	-10.82	-6.66	-1.89
Tangible Book Value Per Share	-0.56	-2.80	-2.62	-0.46	-0.38	-0.11

Source: S&P Global Market Intelligence. Standard template. Financial Sources.